SL1009Beyond's analysis on SL10092026-07-28 — FDA accepts Saol Therapeutics' resubmission of SL1009 (DCA) for PDCD, setting a PDUFA date of Dec 30, 2026Recent news mentioning SL10092026-07-28 — Saol Therapeutics Announces the Acceptance of Resubmission of SL1009 (DCA) by the FDA with PDUFA Date of Dec. 30, 2026Appears alongsideDCAFDAPDUFABrowse the full archive →